TransCode Therapeutics, Inc. Announces Results of Special Meeting
Press Releases
TransCode Therapeutics, Inc.  
February 25, 2025

TransCode Therapeutics, Inc. Announces Results of Special Meeting

BOSTON, Feb. 25, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today held

avatar profile Olean Times Herald

Olean Times Herald


Local & Social